Company: IXHL
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001213900-25-110299
Chunk: 1

Company: Incannex Healthcare Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 1
Chunk 1
---
 
     243,837  
     174,049 
  
    Accumulated deficit 
     (163,963) 
     (157,556)
  
    Foreign currency translation reserve 
     (2,901) 
     (3,124)
  
    Total stockholders’ equity 
     77,008  
     13,389 
  
    Total liabilities and stockholders’ equity 
    $78,720  
    $20,447 

The accompanying notes are an integral part of
these condensed consolidated financial statements.

1

INCANNEX HEALTHCARE INC.

Condensed Consolidated Statements of Operations
and Comprehensive Loss

(unaudited)

(in thousands, except share and per share amounts)

(expressed
in U.S. Dollars, unless otherwise stated)

    For the three months ended September 30, 

    2025  
    2024 
  
    Revenue from customers 
     -  
     74 
  
    Operating expenses: 

    Research and development 
     (1,120) 
     (2,896)
  
    General and administrative 
     (5,674) 
     (3,432)
  
    Total operating expenses 
     (6,794) 
     (6,328)
  
    Loss from operations 
     (6,794) 
     (6,254)
  
    Other income, net: 

    R&D tax incentive 
     389  
     811 
  
    Foreign exchange gains/(losses) 
     (13) 
     (5)
  
    Interest income 
     5  
     28 
  
    Share of earnings (loss) of joint venture 
     6  
     - 
  
    Total other income, net 
     387  
     834 
  
    Loss before income tax expense 
     (6,407) 
     (5,420)
  
    Income tax expense 
     -  
     - 
  
    Net loss 
    $(6,407) 
    $(5,420)
  
    Other comprehensive income/(loss): 

    Currency translation adjustment, net of tax 
     223  
     339 
  
    Total comprehensive loss 
    $(6,184) 
    $(5,081)
  
    Net loss per share: Basic and diluted 
    $(0.02)